Sinopharm Group Co. Ltd. (SHTDF)

2,6400 0,0000 (0,00 %) À partir de 10:40AM EDT. Marché ouvert.

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn

Secteur(s): Healthcare
Secteur d’activité: Medical Distribution
Employés à temps plein: 115 959

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Qingming Yu	Executive Chairman of the Board	896,17k	S.O.	1964
Mr. Yong Liu	President & Executive Director	866,62k	S.O.	1969
Ms. Xiaojuan Li	Chief Financial Officer	S.O.	S.O.	1976
Mr. Yijian Wu	Secretary to the Board, Company Secretary & Authorised Representative	S.O.	S.O.	1970

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Sinopharm Group Co. Ltd. en date du 1 mai 2024 est 7. Les scores principaux sont Audit : 6; Société : 9; Droits des actionnaires : 9; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.